Find your next paid study

National Heart, Lung, and Blood Institute (NHLBI)NCT07806149

~$10 – $5,625

Cardiovascular Disease Discovery Protocol

Background: \- Researchers are interested in studying individuals who have known or suspected metabolic, inflammatory or genetic diseases that may put them at…

Metabolic DiseaseObesityLi-Fraumeni Syndrome+3 more

National Heart, Lung, and Blood Institute (NHLBI)NCT01143454

~$10 – $675

Symptomatic Genetic Dilated Cardiomyopathy (DCM)

An Open-label Extension Study to Assess the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy

Danicamtiv is an investigational medication, which means it is still being studied and has not been approved. The purpose of this study is to learn how well da…

Kardigan, Inc.NCT07771465

Phase 1

A Phase 1 Dose Escalation Trial Evaluating an Intravenously Administered Recombinant Adeno-associated Virus Serotype rh.74 (AAVrh.74) Vector Containing the Human BCL2-associated Athanogene 3 (BAG3) Gene Coding Sequence (RP-A701) in Subjects With Dilated Cardiomyopathy Arising From Pathogenic BAG3 Variants (BAG3-DCM)

This is a Phase 1, open-label, dose-escalation trial to characterize the safety, tolerability, and preliminary efficacy of RP-A701 following a single IV admini…

Dilated Cardiomyopathy (DCM)

Rocket Pharmaceuticals Inc.NCT07137338

Cardiomyopathy, Hypertrophic Obstructive

A Phase 3, Multi-region, Multi-center, Randomized, Double-blind, Active-Comparator-Controlled Trial to Evaluate the Efficacy and Safety of BHB-1893 Compared to Metoprolol in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy

The main purpose of this trial is to find out whether BHB-1893 works better than metoprolol in adults with symptoms of obstructive hypertrophic cardiomyopathy …

Braveheart Bio, Inc.NCT07755904

A Non-interventional, Epidemiologic Study of XLMTM and Clinical Expression in the Liver

XLMTM (X-linked myotubular myopathy) is a serious genetic muscle condition. It is caused by changes in the MTM1 gene which stops or slows down normal muscle de…

X-Linked Myotubular Myopathy

Astellas Gene TherapiesNCT06581146

~$10 – $1,125

Observational

Evaluation of a Pragmatic NT-ProBNP-based Heart Failure Screening Strategy Among Patients With Type 2 Diabetes: STRONG-DM Study (Screening and Treatment Using Risk-based apprOach With NT-ProBNP Guidance in Diabetes Mellitus

A pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinical risk sc…

Type 2 DiabetesDiabetic CardiomyopathyHeart Failure+1 more

University of Texas Southwestern Medical CenterNCT06593327

~$10 – $6,250

Transthyretin Amyloid Cardiomyopathy (ATTR CM)

CLEOPATTRA: Effects of NNC6019-0001 Versus Placebo on Cardiovascular Outcomes in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

This study will find out if a new medicine called NNC6019-0001 can help reduce the risk of heart-related death and illness in participants with a condition cal…

Novo Nordisk A/SNCT07207811

~$10 – $7,500

Phase 1

A Phase 1/2, Open-Label Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of Intravenous ATR 1072 for the Treatment of PRKAG2 Syndrome

ATR 1072 is an investigational medicine being studied in adults with PRKAG2 Syndrome. This study will evaluate the safety of ATR 1072 and how the body processe…

Cardiac GlycogenosisCardiomyopathyHypertrophic+1 more

Atrium TherapeuticsNCT07738107

Phase 2

A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

RESET-Myositis: Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathi…

Idiopathic Inflammatory MyopathyDermatomyositisAnti-Synthetase Syndrome+5 more

~$10 – $7,500

Cabaletta BioNCT06154252

Transthyretin Amyloidosis With Cardiomyopathy

TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

The purpose of this study is to: * Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortality and cardiovascular (CV) events * Ev…

Alnylam PharmaceuticalsNCT07052903

Advancing Bulbar Assessment in Inclusion Body Myositis Through a Multimodal Imaging Approach

This study will evaluate whether neuromuscular ultrasound and MRI can be used as imaging markers of bulbar involvement and swallowing dysfunction in individual…

IBMInclusion Body MyositisMyopathy+3 more